Recent Comments

Comment RSS

Impotence News and Research RSS Feed - Impotence News and Research

Erectile dysfunction, sometimes called "impotence," is the repeated inability to get or keep an erection firm enough for sexual intercourse. The word "impotence" may also be used to describe other problems that interfere with sexual intercourse and reproduction, such as lack of sexual desire and problems with ejaculation or orgasm. Using the term erectile dysfunction makes it clear that those other problems are not involved.

Pfizer’s Revatio Injection receives FDA approval

20. November 2009 09:18
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations. [More]

Cancer screening methods are not perfect: Experts

11. November 2009 06:07
In a recent New York Times article, the American Cancer Society (ACS) ignited a major controversy over the benefits of cancer screening, specifically with regards to their breast and prostate cancer guidelines. In the article, Dr. Otis Brawley, chief medical officer of the ACS, responded to a study in the current issue of the Journal of the American Medical Association. [More]

Posted in: Men's Health News | Women's Health News

Tags: , , , , ,

Elevated PSA levels in men are not necessarily a predictor of the need for a prostate biopsy: Study

7. November 2009 00:23
Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. [More]

Health Canada approves the Zenith Branch Endovascular Graft-Iliac Bifurcation

4. November 2009 02:03
Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the body’s largest arteries with an endovascular graft delivered during a minimally invasive procedure without blocking a critical artery. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: ,

Adenosine deaminase enzyme therapy offers hope for priapism

27. October 2009 06:36
For men coping with painful erections lasting for long periods of time, or priapism, new research published online in The FASEB Journal (http://www.fasebj.org) offers hope. That's because researchers from the United States and China show that the enzyme adenosine deaminase may prevent priapism from progressing to penile fibrosis, a condition associated with the build up of scar tissue and eventual impotence. [More]

Posted in: Men's Health News

Tags: , , , , , ,

BioMarin Pharmaceutical announces the acquisition of Huxley Pharmaceuticals

27. October 2009 00:45
BioMarin Pharmaceutical Inc. announced today that it has acquired Huxley Pharmaceuticals, Inc. (Huxley), which has rights to a proprietary form of 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). [More]

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

21. October 2009 06:01
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York. [More]

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

14. October 2009 02:14
Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults. [More]

Clinical study results of prostate cancer patients treated with CyberKnife Radiosurgery released

1. October 2009 09:07
Accuray Incorporated, a global leader in the field of radiosurgery, announced today publication of results from a study of early stage prostate cancer patients treated with CyberKnife Radiosurgery. [More]

Effective decision support tools may help decide whether or not to undertake PSA screening

30. September 2009 01:46
Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain. [More]

Posted in: Men's Health News | Device / Technology News

Tags: , , ,

Study compares benefits of laparoscopic and traditional open surgery for prostate cancer

24. September 2009 06:27
The more things change, the more they stay the same, as the proverb goes. A study appearing in an upcoming edition of The Journal of Oncology appears to prove just that. The study compares the benefits of laparoscopic surgery versus traditional open surgery in the treatment of prostate cancer. With traditional surgery, surgeons remove the prostate gland via an incision below the belly button. [More]

Posted in: Men's Health News | Medical Procedure News

Tags: , , , , , ,

Final results of SAPHRIS clinical study released

14. September 2009 07:51
Schering-Plough Corporation today reported final results of a SAPHRIS(R) (asenapine) long-term schizophrenia relapse prevention clinical study. [More]

Prostate cancer treatment options discussed in a study

9. September 2009 03:51
A new study in the Journal of the American Medical Association (JAMA) appears to support the theory outlined in earlier studies that men with more advanced forms of prostate cancer don't benefit from a combination of hormone and radiation therapy. [More]

Pfizer agrees to a $1.2 billion fine for fraudulent drug marketing practices

3. September 2009 00:53
As part of its ongoing campaign to lower drug prices and increase access, AIDS Healthcare Foundation (AHF) today lauded the U.S. Justice Department’s crackdown on Pfizer, Inc. for its fraudulent drug marketing practices. [More]

Posted in: Business / Finance | Pharmaceutical News

Tags: , , , , ,

New findings on molecular imaging and prostate cancer

2. September 2009 04:51
A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.